Previous studies have illustrated that fingolimod (FTY-720, an analog of S1PR, the first generation of S1P modulators) alleviated brain injury or promoted functional recovery by reducing cerebral lymphocyte infiltration after ischemic or hemorrhagic stroke [17, 90-92]. This evidence concerns the gene MBTPS1 and hemorrhagic stroke.